Healthcare Utilization and Costs After Appropriate or Inappropriate Implantable Defibrillator Shocks: A Retrospective

Takashi Noda1, Tomoko Matsumoto2, Yuji Tanaka2

  • 1Cardiovascular Center, Kindai University Hospital, Sakai, Osaka, Japan.

Insights

Implantable cardioverter-defibrillator (ICD) and CRT-D shocks in Japan lead to significant healthcare utilization and costs, especially for appropriate shocks requiring hospitalization. Further research is needed to optimize patient management and resource use.

Area of Science:

  • Cardiology
  • Health Economics
  • Medical Device Technology

Background:

  • Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy with defibrillators (CRT-Ds) are crucial for preventing sudden cardiac death.
  • Limited data exists on healthcare utilization and costs following ICD/CRT-D shock events specifically within Japan.

Purpose of the Study:

  • To analyze real-world data on healthcare utilization and costs associated with ICD/CRT-D shock events in Japan.
  • To provide insights into the economic impact of these events in the Japanese healthcare system.

Main Methods:

  • Retrospective analysis of real-world data from four tertiary hospitals in Japan (January 2022 - June 2024).
  • Inclusion of adult patients with ICD/CRT-D implants, focusing on those experiencing shock events.
  • Examination of hospitalization rates, duration of stay, and associated healthcare costs.

Main Results:

  • Out of 1,807 patients, 84 experienced 146 ICD/CRT-D shock events (4.6%); 33 patients had multiple episodes.
  • Appropriate shocks (83.6%) were linked to significantly longer hospital stays and higher costs compared to inappropriate shocks (16.4%).
  • Hospitalization was required in 37.7% of shock cases.

Conclusions:

  • ICD/CRT-D shock events in Japan incur substantial healthcare utilization and costs, particularly appropriate shocks.
  • Findings underscore the need for optimized management strategies to improve patient care and resource allocation in Japan.
  • This study highlights the importance of real-world data in understanding the economic burden of cardiac device therapies.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
633
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
748
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670